Advertisement
Screener

Encompass Health Corporation (EHC) Overview

Encompass Health Corporation (EHC) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 1.54; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 1.93; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 1.24; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 1.39; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$89.14$98.17$108.12$119.07$131.13$144.422025-11-062026-11-06$40.79$52.53$67.64$87.10$112.15$144.422021-11-082026-11-06$29.18$40.59$56.46$78.54$109.24$151.952016-11-072026-11-06$5.14$10.26$20.50$40.94$81.77$163.322006-11-062026-11-06$0.30$1.07$3.76$13.21$46.45$163.321986-09-242026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$137.54
Previous close
$123.56
Change
$13.98
Change (%)
11.31%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

EHC
+17.08%
S&P 500
(m)

1 year

EHC
-1.13%
S&P 500
(m)

3 years

EHC
+87.66%
S&P 500
(m)

5 years

EHC
+113.44%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 1.54

1.161.401.631.872.1131 Mar 2025: estimate (m); actual 1.4831 Mar 2025(m)30 Jun 2025: estimate (m); actual 1.3930 Jun 2025(m)30 Sept 2025: estimate (m); actual 1.2430 Sept 2025(m)31 Mar 2026: estimate (m); actual 1.9331 Mar 2026(m)30 Jun 2026: estimate (m); actual 1.5430 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)1.54(m)(m)
1 Jan 202631 Mar 2026(m)1.93(m)(m)
1 Jul 202530 Sept 2025(m)1.24(m)(m)
1 Apr 202530 Jun 2025(m)1.39(m)(m)
1 Jan 202531 Mar 2025(m)1.48(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 5.54

2.623.404.174.955.7231 Dec 2021: estimate (m); actual 4.1131 Dec 2021(m)31 Dec 2022: estimate (m); actual 2.7031 Dec 2022(m)31 Dec 2023: estimate (m); actual 3.4731 Dec 2023(m)31 Dec 2024: estimate (m); actual 4.4631 Dec 2024(m)31 Dec 2025: estimate (m); actual 5.5431 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)5.54(m)(m)
1 Jan 202431 Dec 2024(m)4.46(m)(m)
1 Jan 202331 Dec 2023(m)3.47(m)(m)
1 Jan 202231 Dec 2022(m)2.70(m)(m)
1 Jan 202131 Dec 2021(m)4.11(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 1.60B ■ Earnings 0.15B — Profit margin 9.63%

-0.19B7.6%0.47B9.5%1.13B11.4%1.79B13.3%30 Sept 2025: revenue 1.48B; earnings 0.13B; profit margin 8.56%30 Sept 202531 Dec 2025: revenue 1.54B*; earnings 0.15B*; profit margin 9.46%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 1.59B; earnings 0.19B; profit margin 12.26%31 Mar 202630 Jun 2026: revenue 1.60B; earnings 0.15B; profit margin 9.63%30 Jun 2026

31 Dec 2025 ■ Revenue 5.94B ■ Earnings 0.57B — Profit margin 9.54%

-0.71B5.2%1.74B7.0%4.19B8.8%6.65B10.5%31 Dec 2022: revenue 4.35B; earnings 0.27B; profit margin 6.23%31 Dec 202231 Dec 2023: revenue 4.80B; earnings 0.35B; profit margin 7.33%31 Dec 202331 Dec 2024: revenue 5.37B; earnings 0.46B; profit margin 8.48%31 Dec 202431 Dec 2025: revenue 5.94B; earnings 0.57B; profit margin 9.54%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$137.54(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$137.54High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning EHC

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$621.00M
Profit margin
10.01%
Return on assets · 12 month
8.72%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
31.57K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
859.58K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
0.65%*
Total return · month
2.24%*
Total return · quarter
22.69%*
Total return · half year
27.13%*
Total return · year to date
17.08%*
Total return · 1 year
-1.13%*
Total return · 3 years
87.66%*
Total return · 5 years
113.44%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$6.21B
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Encompass Health Corporation Overview

View more →

(m)

(m)

SEC CIK
785161
Industry (SIC)
8060 Services-Hospitals
Country of operation
United States
Business address
9001 LIBERTY PARKWAY, BIRMINGHAM, Alabama, 35242, United States
Fiscal year end
1231
Phone
205-967-7116

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pediatrix Medical Group, Inc. (MD)United States$2.084B11.76